Bypass surgery is recommended over stents when coronary artery disease is too widespread or too complex for stents to treat effectively. The core reason is durability: at five years, about 26% of stent patients need another procedure, compared to roughly 14% of bypass patients. But the choice between the two isn’t just about preference. It depends on how many arteries are blocked, where the blockages sit, how complex the anatomy is, and whether you have diabetes.
How Complexity Drives the Decision
Cardiologists use a scoring system called the SYNTAX score to rate how complex your coronary artery disease is. It accounts for the number of blockages, their location, and how difficult they’d be to treat. The score falls into three ranges: low (0 to 22), intermediate (23 to 32), and high (33 or above).
For patients with low scores, stents and bypass produce similar outcomes, and stents are a reasonable option. But as complexity rises, the gap widens dramatically. In patients scoring 33 or higher, those treated with stents had nearly double the rate of major cardiac and stroke events compared to bypass patients (28.2% vs. 15.4%). Guidelines are clear that stents should generally be avoided at this complexity level.
This matters because complex disease often means blockages in multiple locations, at branch points, or in long segments of artery. Stents work well for short, isolated blockages. Once you’re dealing with three or more diseased vessels or blockages in difficult positions, a surgeon can route grafts around all of them in a single operation, achieving complete blood flow restoration that stents often can’t match.
When Multiple Vessels Are Involved
Bypass surgery’s biggest advantage shows up in multivessel disease, where two or three major coronary arteries are significantly blocked. A large meta-analysis found that stent patients with multivessel disease had a 28% higher risk of death over 10 years compared to bypass patients. The reason comes down to completeness: a surgeon can graft every blocked vessel in one procedure, while placing stents in every vessel is technically harder and sometimes impossible.
When stents can’t reach every blockage, you’re left with “incomplete revascularization,” meaning some parts of the heart still aren’t getting adequate blood flow. Bypass surgery achieves complete revascularization at higher rates, which translates directly into better long-term survival.
Why Diabetes Changes the Calculation
Diabetes is one of the strongest factors pushing the decision toward bypass. Diabetic patients have a particular type of coronary disease that tends to be more diffuse, affecting longer stretches of artery rather than creating single, discrete blockages. Stents cover a specific spot. Bypass grafts supply blood downstream of an entire diseased segment, which better addresses how diabetes damages arteries.
In a study of nearly 4,800 matched diabetic patients with acute coronary events, bypass surgery reduced five-year mortality compared to stents (23.4% vs. 26.5%) and cut major cardiovascular events by 19%. Among the sickest patients in that study, those who had a surgical consultation but still received stents fared far worse: 47.1% had died at five years compared to 37.8% of bypass patients. Current guidelines recommend bypass over stents for most diabetic patients with multivessel disease, even when SYNTAX scores are in the low or intermediate range. The exception is isolated single-vessel disease, where stents remain appropriate.
Left Main Disease: A Special Case
The left main coronary artery feeds roughly two-thirds of the heart’s blood supply. When it’s significantly blocked, the stakes are high. Historically, this was considered bypass-only territory. That has loosened somewhat with modern stents, but the picture is nuanced.
At 10 years, overall mortality rates for left main disease are similar between stents and bypass (about 21% vs. 23%), and the difference isn’t statistically significant. For patients with straightforward left main blockages and low SYNTAX scores, stents can be a reasonable alternative. But when left main disease coexists with complex blockages elsewhere, or when diabetes is present (where 10-year mortality reaches roughly 29% regardless of approach), bypass remains the default recommendation because it addresses the full picture of disease rather than just the left main blockage.
Stents Need Replacing More Often
One of the most practical differences between the two approaches is how often you’ll need another procedure. Data from the landmark SYNTAX trial showed that 25.9% of stent patients required repeat revascularization within five years, compared to 13.7% of bypass patients. That’s nearly double the reintervention rate.
Stents can develop scar tissue growth inside them (called restenosis) or new blockages can form at their edges. Bypass grafts, particularly those using an artery from the chest wall, remain open for decades in most patients. This durability gap matters for younger patients or anyone who wants to minimize the number of procedures they’ll face over a lifetime.
From a cost perspective, bypass surgery costs more upfront. But when you factor in the cost of repeat stent procedures, medications, and rehospitalizations over a lifetime, bypass is cost-effective at roughly $16,500 per quality-adjusted life-year gained. For patients with simpler disease (low SYNTAX scores or isolated left main blockages), stents can actually be the more economical choice because the reintervention rates are lower in those groups.
Recovery Is the Tradeoff
The main reason patients prefer stents is recovery. A stent procedure involves threading a catheter through your wrist or groin artery. You’re typically home the next day and back to normal activities within a week. Bypass surgery requires opening the chest, and recovery takes six to twelve weeks before you can return to work and normal physical activity. The surgery also carries a small stroke risk of roughly 1 to 2%.
Modern bypass techniques have improved outcomes. Standard bypass uses a heart-lung machine to temporarily stop the heart during surgery. An alternative “off-pump” approach operates on the beating heart, which cuts the short-term stroke rate (1.3% vs. 1.8%). However, off-pump surgery is associated with slightly higher long-term mortality and more need for repeat procedures, so most surgeons still favor the traditional approach for the majority of patients.
How the Decision Gets Made
In most hospitals, a “heart team” of cardiologists and cardiac surgeons reviews your imaging together. They calculate your SYNTAX score, assess your other health conditions, and factor in your age and personal preferences. The general framework looks like this:
- Single-vessel disease: Stents are typically preferred regardless of other factors.
- Two-vessel disease, low complexity: Either option works. Recovery preference often tips the decision.
- Three-vessel disease: Bypass is favored, especially with moderate or high complexity scores.
- Diabetes with multivessel disease: Bypass is strongly favored.
- High SYNTAX score (33+): Bypass is recommended regardless of other factors.
The decision isn’t always clear-cut, and there are patients who are poor surgical candidates due to age, lung disease, or other conditions. In those cases, stents may be the better choice even when anatomy favors bypass, simply because surviving the surgery itself becomes the concern. The best outcomes happen when both a cardiologist and a surgeon weigh in before a decision is made.